Coronary Stents Market, by Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), by Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable / Permanent Stents and Degradable / Temporary Stents)), by End User (Hospitals, Specialty Clinics and Ambulatory Surgical Centers) and by Region - Size, Share, trends, and Forecast to 2026

  • Published On : Aug 2018 |
  • Pages : 155 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Coronary Stents Market Insights – Unblocking the Blocked Paths

Stents are medical devices intended to use for the treatment of blocked vascular paths and the procedure used to reduce the blockages is known as percutaneous transluminal coronary angioplasty (PTCA). The stents used for arterial blockage are known as coronary stents or heart stents. Coronary stents can be either of the three types, which are bare metal stents, drug eluting stents, and bioabsorbable stents. Although bare metal stents dramatically improves angiographic and clinical outcome of patients, the rate of restenosis is 20–30%. This is a major factor limiting the usage of bare metal stents and development of next generation of drug eluting stents.

The global coronary stents market size is estimated to be valued at US$ 7,814.4 million in 2018, and is expected to witness a CAGR of 6.8% over the forecast period (2018 – 2026).

Figure 1. Global Coronary Stents Market Share (%), By Product Type

Coronary Stents  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Increasing adoption of stents implantation in cardiovascular blockage is a major factor for the coronary stents market growth

Stents implantation being non-invasive surgery is increasingly gaining popularity as compared to more invasive bypass surgeries, owing to lower rate of discomfort and shorter recovery time. Moreover, cardiovascular diseases are considered as the leading cause of morbidity and mortality across the world, in turn fueling demand for coronary stents.  According to American Heart Association, 2015, more than 17.3 million people die every year due to cardiovascular disease.

Moreover, increasing research initiatives by local manufacturers to enhance their regional coronary stents market share is boosting the coronary stents market growth. For instance, Qvanteq, a Switzerland-based company, is engaged in developing Qstents, a coronary stent system, consisting of various length and diameter combinations, in collaboration with Cardialysis BV, a specialized Clinical Research Organization (CRO). Such research by local manufacturers are expected to provide products at relatively lower cost, thus increasing affordability and in turn the product usage. This is expected to aid in the market growth.

Moreover, technological advancement such as nano-coated coronary stents are propelling its adoption, thus aiding in the market growth. For instance, in 2017, CeloNova BioSciences Inc. is evaluating its proprietary Cobra PzF Nanocoated Coronary Stents (NCS) in patients with high bleeding risk. Nanocoated coronary stents are alternate therapy for patients incompatible to drug eluting stents and long term antiplatelet therapy.

Factors such as risky stent implantation is expected to negatively affect growth of the market. For instance, stents implantation is prone to stents displacement and re-narrowing of the arteries. Re-blockages are addressed by administering blood-thinning drugs, which is leading to high adoption of drug eluting coronary stents.

Coronary Stents Market Regional Outlook - Asia Pacific to be the fastest growing market over the forecast period

In terms of region, the coronary stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. Europe holds dominant position in the coronary stents market, owing to presence of large obese population with high risk of coronary blockage in the region.

According to European Heart Network’s European Cardiovascular Disease Statistics 2017, in 2015, new cases registered with cardiovascular disease in Europe was around 11.3 million with nearly 6.1 million new cases of cardiovascular disease in the European Union. The number is further expected to increase with increase in the rate of obese population.

However, Asia Pacific coronary stents market is expected to witness significant growth due to lower surgical cost in emerging countries such as India and China, which is attracting medical tourist. For instance, countries like Thailand and Malaysia is the most preferred destination for medical tourist, owing to its competitively affordable medical services. According to Malaysia Healthcare Travel Council, the country is expected to host medical facilities for more than one million medical tourist, accounting for revenues of US$ 310.4 million for 2017.

Moreover, increasing expansion of regional key players in the other regions is also expected to influence the regional market growth. For instance, in April 2018, Terumo Corporation, Tokyo-based medical device company, received CE mark for Ultimaster TANSEI drug-eluting stent, which was launched in the European market in May 2018. Furthermore, the company also aims to expand in Middle East, Latin America, and Asia in the near future.

Figure 2. Global Coronary Stents Market Value (US$ Mn), By Region

Coronary Stents  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2018)

Key players in the global coronary stents market

Major players operating in the coronary stents market include Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA

Coronary stents are small interventional device used for opening the blocked arteries and for prevention of re-narrowing of the arteries. The global coronary stents market report serves are a valuable tool for evaluation of coronary stents present market scenario and the trends over the forecast period of 2016 - 2026. The report delivers in depth analysis of factors driving as well as restraining the market growth and also enlightens further market opportunity for the manufacturers. Report also covers key developments and company’s strategies to grab the market share.

Market Dynamics

Increasing product launches coupled with increasing geographical approval in drug eluting coronary stents is propelling growth of the coronary stents market. For instance, in May 2018, Abbott received the U.S. FDA approval for XIENCE Sierra, the new generation of everolimus-eluting coronary stent. The XIENCE received approval from the Japan’s regulatory body in April 2018, and CE mark from European regulatory bodies in 2017. Furthermore, companies are also evaluating and launching products with novel material, such as with metal like cobalt chromium and fully biodegradable stents. For instance, in 2017, Biotronik received FDA approval for PRO-Kinetic energy cobalt chromium-based bare metal coronary stent system to treat coronary artery blockage. However, coronary stents market is also subjected to the factors such as stringent regulatory approval policies for the interventional devices and medical complications such as restenosis and thrombosis, which are expected to restrain coronary stents market growth.

Key features of the study:

  • This report provides in-depth analysis of the coronary stents market and its application, market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global coronary stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Boston Scientific Corporation, Abbott, Medtronic plc, B. Braun Melsungen AG, Stentsy SA, Terumo Interventional Systems, Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc. and Arterial Remodeling Technologies SA
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
  • The global coronary stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of coronary stents, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the coronary stents market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Coronary Stents Market, By Product Type:
    • Bare-Metal Stents
    • Drug Eluting Stents
    • Bioabsorbable Stents
  • Global Coronary Stents Market, By Material:
    • Metallic
      • Stainless Steel
      • Silicon Carbide
      • Titanium Nitride Oxide
      • Cobalt Chromium
      • Platinum Chromium
      • Others
    • Polymeric
      • Non-degradable / Permanent Stents
      • Degradable / Temporary Stents
  • Global Coronary Stents Market, By End Users:
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers
  • Global Coronary Stents Market, By Region:
    • North America
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By country:
        • Germany
        • U.K.
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Bare-Metal Stents
        • Drug Eluting Stents
        • Bioabsorbable Stents
      • By Material:
        • Metallic
          • Stainless Steel
          • Silicon Carbide
          • Titanium Nitride Oxide
          • Cobalt Chromium
          • Platinum Chromium
          • Others
        • Polymeric
          • Non-degradable / Permanent Stents
          • Degradable / Temporary Stents
      • By End Users:
        • Hospitals
        • Specialty Clinics
        • Ambulatory Surgical Centers
      • By country:
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Boston Scientific Corporation*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Market Strategies
    • Abbott
    • Medtronic plc
    • B. Braun Melsungen AG
    • Stentsy SA
    • Terumo Interventional Systems
    • Kyoto Medical Planning Co., Ltd.
    • QualiMed
    • Elixir Medical Corporation
    • ENDOCOR GmbH
    • BIOTRONIK SE & Co. KG
    • Amaranth Medical, Inc.
    • Arterial Remodeling Technologies SA

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
    • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Material
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Industry Trends
    • Technological Advancement
    • Recent Approvals
    • Regulatory Scenario
    • Epidemiology
    • PEST Analysis
  4. Global Coronary Stents Market, By Product Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Bare-Metal Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Drug Eluting Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Bioabsorbable Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Coronary Stents Market, By Material, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Metallic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Stainless Steel
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Silicon Carbide
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Titanium Nitride Oxide
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Cobalt Chromium
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Platinum Chromium
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Polymeric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Non-degradable / Permanent Stents
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
        • Degradable / Temporary Stents
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Coronary Stents Market, By End User, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Specialty Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Coronary Stents Market, By Regions, 2016–2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Material, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
        • Northern Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Boston Scientific Corporation*
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Medtronic plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Stentys SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Terumo Interventional Systems
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Kyoto Medical Planning Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • QualiMed
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Elixir Medical Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • ENDOCOR GmbH
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • BIOTRONIK SE & Co. KG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Amaranth Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
      • Arterial Remodeling Technologies SA
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Market Strategies
  9. Analyst Views
  1. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 32 market data tables and 30 figures on “Coronary Stents Market - Global forecast to 2026”.

 

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.